BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34207366)

  • 21. Three case reports of inherited antithrombin deficiency in China: double novel missense mutations, a nonsense mutation and a frameshift mutation.
    Deng H; Shen W; Gu Y; Ma X; Zhang J; Zhang L
    J Thromb Thrombolysis; 2012 Aug; 34(2):244-50. PubMed ID: 22535529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study.
    Salim S; Zarrouk M; Elf J; Gottsäter A; Sveinsdottir S; Svensson P; Acosta S
    J Thromb Thrombolysis; 2019 May; 47(4):572-577. PubMed ID: 30756343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
    Orlando C; Heylen O; Lissens W; Jochmans K
    Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of hereditary thrombophilia in a Chinese Han patient with both antithrombin deficiency and Factor V Leiden: A case report and literature review.
    Li X; Lin W; Zhu L; Wang Y; Liu S; Liu J; Du H; Fang S
    Neuro Endocrinol Lett; 2017 Dec; 38(7):479-483. PubMed ID: 29369598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
    Brenner B; Zivelin A; Lanir N; Greengard JS; Griffin JH; Seligsohn U
    Blood; 1996 Aug; 88(3):877-80. PubMed ID: 8704244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
    Martinelli I; Mannucci PM; De Stefano V; Taioli E; Rossi V; Crosti F; Paciaroni K; Leone G; Faioni EM
    Blood; 1998 Oct; 92(7):2353-8. PubMed ID: 9746774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted next-generation sequencing reveals novel and known variants of thrombophilia associated genes in Saudi patients with venous thromboembolism.
    Athar M; Ghita IS; Albagenny AA; Abduljaleel Z; Shadab G; Elsendiony A; Halawani SH; Alkazmi MM; Alquthami K; Alkhuzae MM; Althebyani AA; Bogari NM; Dannoun A; Al-Allaf FA
    Clin Chim Acta; 2021 Aug; 519():247-254. PubMed ID: 34015304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
    Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
    Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Risk Factors in Venous Thromboembolism.
    Hotoleanu C
    Adv Exp Med Biol; 2017; 906():253-272. PubMed ID: 27638626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of inherited thrombophilia: guide for genetics professionals.
    Varga EA; Kujovich JL
    Clin Genet; 2012 Jan; 81(1):7-17. PubMed ID: 21707594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family.
    Simioni P; Tormene D; Luni S; Caldato M; Girolami A
    Blood Coagul Fibrinolysis; 2000 Jun; 11(4):379-84. PubMed ID: 10847426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications.
    Kovac M; Mitic G; Mikovic Z; Mandic V; Miljic P; Mitrovic M; Tomic B; Bereczky Z
    Thromb Res; 2019 Jan; 173():12-19. PubMed ID: 30458337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?
    Kenet G; Limperger V; Shneyder M; Nowak-Göttl U
    Blood Cells Mol Dis; 2017 Sep; 67():18-22. PubMed ID: 28010922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.
    Kim HJ; Seo JY; Lee KO; Bang SH; Lee ST; Ki CS; Kim JW; Jung CW; Kim DK; Kim SH
    Haematologica; 2014 Mar; 99(3):561-9. PubMed ID: 24162787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study.
    El-Galaly TC; Severinsen MT; Overvad K; Steffensen R; Vistisen AK; Tjønneland A; Kristensen SR
    Br J Haematol; 2013 Mar; 160(6):838-41. PubMed ID: 23150947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and functional characterization of rare compound heterozygous mutations in the SERPINC1 gene causing severe thrombophilia.
    Zhang K; Zhang H; Yu D; Pan J; Wang M; Xie H
    Gene; 2024 Mar; 897():148085. PubMed ID: 38104950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
    Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Roy DC; Wang TF; Carrier M; Mallick R; Burger D; Hawken S; Wells PS
    J Thromb Haemost; 2023 Nov; 21(11):3184-3192. PubMed ID: 37536569
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.